Bruce A. Kehr
Fondateur chez Potomac Psychiatry
Profil
Dr. Bruce A.
Kehr, MD, is President & Founder at Potomac Psychiatry and Chairman & Chief Executive Officer at Informedix Holdings, Inc. He is on the Board of Directors at University of Pennsylvania.
He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from Georgetown University.
Postes actifs de Bruce A. Kehr
| Sociétés | Poste | Début |
|---|---|---|
| University of Pennsylvania | Directeur/Membre du Conseil | 08/02/2010 |
| Potomac Psychiatry | Fondateur | 08/02/2010 |
Painscript Corp.
 Painscript Corp. Internet Software/ServicesTechnology Services Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million. | Président | - |
Anciens postes connus de Bruce A. Kehr
| Sociétés | Poste | Fin |
|---|---|---|
Informedix Holdings, Inc.
 Informedix Holdings, Inc. Medical SpecialtiesHealth Technology InforMedix Holdings, Inc. develops integrated portable patient monitoring units, hardware, software and networked communications system to enable consumers, pharmacists, health plans, disease management organizations, pharmaceutical and biomedical companies, medical researchers and physicians to monitor and manage patients' medication adherence and clinical response. The company was founded on January 19, 2000 is headquartered in Rockville, MD. | Directeur Général | - |
Formation de Bruce A. Kehr
| University of Pennsylvania | Undergraduate Degree |
| Georgetown University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Informedix Holdings, Inc.
Informedix Holdings, Inc. Medical SpecialtiesHealth Technology InforMedix Holdings, Inc. develops integrated portable patient monitoring units, hardware, software and networked communications system to enable consumers, pharmacists, health plans, disease management organizations, pharmaceutical and biomedical companies, medical researchers and physicians to monitor and manage patients' medication adherence and clinical response. The company was founded on January 19, 2000 is headquartered in Rockville, MD. | Health Technology |
| Potomac Psychiatry | |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million. | Technology Services |
